A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J
Anesth Analg 2004;99:262-271.
Review by
How effective is acute normovolaemic haemodilution in femoro-distal bypass surgery?
Spark JI, Chetter IC, Kester RC, Scott DJA
Cardiovasc Surg 2002;10(5):460-463.
Review by Van der Linden P
Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty.
Friederichs MG, Mariani EM, Bourne MH
J Arthroplasty 2002;17(3):298-303.
Review by Hansen E
Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
Ng HJ, Lee LH
Ann Acad Med Singapore 2002;31(2):241-244.
Review by Aldouri M
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659